{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:15:28Z","timestamp":1791274528134,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.semarthrit.2003.09.012","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T05:21:57Z","timestamp":1081488117000},"page":"336-351","source":"Crossref","is-referenced-by-count":116,"title":["Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature"],"prefix":"10.1016","volume":"33","author":[{"given":"Jessica E.","family":"Nord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prediman K.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee Z.","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2003.09.012_BIB1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(51)91643-1","article-title":"Treatment of lupus erythematosus with mepacrine","volume":"2","author":"Page","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.51.12.1318","article-title":"Continuation of long-term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis","volume":"51","author":"Morand","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB3","first-page":"6","article-title":"Hydroxychloroquine therapy in rheumatic diseases","volume":"44","author":"Anderson","year":"1996","journal-title":"Bull Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0307-742X(21)00317-9","article-title":"Chloroquine and hydroxychloroquine in rheumatological therapy","volume":"6","author":"Mackenzie","year":"1980","journal-title":"Clin Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1988.tb05281.x","article-title":"A dose-ranging study of the pharmacokinetics of hydroxychloroquine following intravenous administration to healthy volunteers","volume":"26","author":"Tett","year":"1988","journal-title":"Br J Clin Pharmacol"},{"issue":"1A","key":"10.1016\/j.semarthrit.2003.09.012_BIB6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"McChesney","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB8","first-page":"323","article-title":"The efficacy of antimalarials in systemic lupus erythematosus","volume":"2","author":"Rudnicki","year":"1975","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3949\/ccjm.25.2.95","article-title":"Further observations on the use of 4-aminoquinolone compounds in patients with rheumatoid arthritis or related diseases","volume":"25","author":"Scherbel","year":"1958","journal-title":"Cleveland Clin Q"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","article-title":"The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis","volume":"33","author":"Felson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/106002809102501202","article-title":"Steady-state pharmacokinetics of hydroxychloroquine in rheumatoid arthritis patients","volume":"25","author":"Miller","year":"1991","journal-title":"DICP"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","article-title":"Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis","volume":"46","author":"Munster","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/33.3.235","article-title":"Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis","volume":"33","author":"McLachlan","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/chir.530060420","article-title":"Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of recemate","volume":"6","author":"Tett","year":"1994","journal-title":"Chirality"},{"issue":"1A","key":"10.1016\/j.semarthrit.2003.09.012_BIB16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(83)91264-0","article-title":"Pharmacologic actions of 4-aminoquinolone compounds","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB17","first-page":"1656","article-title":"Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis","volume":"27","author":"Tett","year":"2000","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2003.09.012_BIB18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339600500104","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI101980","article-title":"Studies on the chemotherapy of the human malarias: VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinolone","volume":"27","author":"Berliner","year":"1948","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0889-857X(21)00233-7","article-title":"Antimalarial agents and lupus","volume":"20","author":"Wallace","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB21","first-page":"2919","article-title":"Canadian rheumatology association","volume":"27","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB22","first-page":"477","article-title":"Spectrophotometric determination and distribution of chloroquine in human tissues","volume":"52","author":"Prouty","year":"1958","journal-title":"J Lab Clin Med"},{"issue":"1A","key":"10.1016\/j.semarthrit.2003.09.012_BIB23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(83)91267-6","article-title":"Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy","volume":"75","author":"Bernstein","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2125.1993.tb05897.x","article-title":"Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate","volume":"36","author":"McLachlan","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2003.09.012_BIB25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-4886(81)90090-X","article-title":"Inhibition of lysosomal function in red and white skeletal muscles by chloroquine","volume":"71","author":"Stauber","year":"1981","journal-title":"Exp Neurol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/infdis\/164.4.830","article-title":"Quinacrine inhibits tumor necrosis factor production by human macrophages in vitro","volume":"164","author":"Picot","year":"1991","journal-title":"J Infect Dis"},{"issue":"1A","key":"10.1016\/j.semarthrit.2003.09.012_BIB28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9343(83)91266-4","article-title":"Immunosuppressive potential of antimalarials","volume":"75","author":"Salmeron","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.32.4.316","article-title":"Action of chloroquine phosphate in rheumatoid arthritis. I. Immunosuppressive effect","volume":"32","author":"Panayi","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1067\/mai.2001.116004","article-title":"Hydroxychloroquine sulphate inhibits in vitro apoptosis of circulating lymphocytes in patients with systemic lupus erythematosus","volume":"19","author":"Liu","year":"2001","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.1780400522","article-title":"Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine","volume":"40","author":"Meng","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH, and the antimalarial action of chloroquine","volume":"235","author":"Homewood","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB33","first-page":"1221","article-title":"Chloroquine related cardiac toxicity","volume":"25","author":"Veinot","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780090611","article-title":"Lysosomes and joint disease","volume":"9","author":"Weissman","year":"1966","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0049-0172(87)90023-0","article-title":"Antimalarials in rheumatology","volume":"16","author":"Maksymowych","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00005072-197007000-00010","article-title":"Experimental chloroquine myopathy","volume":"29","author":"MacDonald","year":"1970","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mus.880020509","article-title":"Chloroquine-induced cytosomes with curvilinear profiles in muscle","volume":"2","author":"Neville","year":"1979","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.29.3.255","article-title":"Experimental chloroquine myopathy","volume":"29","author":"Smith","year":"1966","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"1A","key":"10.1016\/j.semarthrit.2003.09.012_BIB39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(83)91268-8","article-title":"Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment","volume":"75","author":"Rynes","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB40","first-page":"2703","article-title":"Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation","volume":"27","author":"Bienfang","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB41","first-page":"472","article-title":"Dose relationships in patients with early chloroquine retinopathy","volume":"14","author":"Easterbrook","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1755-3768.1966.tb08039.x","article-title":"Ocular damage in chloroquine therapy","volume":"44","author":"Nylander","year":"1966","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB43","first-page":"226","article-title":"Ocular toxicity of systemic drugs","volume":"31","author":"Sammartino","year":"1985","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ard.55.3.187","article-title":"Retinal toxicity in long term hydroxychloroquine treatment","volume":"55","author":"Mavrikakis","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9394(14)76853-9","article-title":"Hydroxychloroquine retinopathy","volume":"112","author":"Weiner","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB46","first-page":"292","article-title":"Ocular safety of hydroxychloroquine","volume":"23","author":"Bernstein","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9394(87)90005-5","article-title":"Hydroxychloroquine therapy in massive total doses without retinal toxicity","volume":"104","author":"Johnson","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archopht.1982.01030030083006","article-title":"Hydroxychloroquine","volume":"100","author":"Tobin","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB49","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.1780400817","article-title":"Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice","volume":"40","author":"Levy","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/096120339300200604","article-title":"Hydroxychloroquine, dosage parameters and retinopathy","volume":"2","author":"Spalton","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB51","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/1529-0131(200108)44:8<1959::AID-ART334>3.0.CO;2-A","article-title":"Early hydroxychloroquine macular toxicity","volume":"44","author":"Warner","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB52","first-page":"1377","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"109","author":"Marmor","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB53","first-page":"385","article-title":"Hydroxychloroquine toxicity despite normal dose therapy","volume":"25","author":"Falcone","year":"1993","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.48.7.542","article-title":"Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis","volume":"48","author":"Pavelka","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ard.41.1.52","article-title":"Chloroquine retinopathy","volume":"41","author":"Marks","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB56","first-page":"800","article-title":"Laboratory studies of the 4-aminoquinolone antimalarials: I. Some biochemical characteristics of chloroquine, hydroxychloroquine, and SN-7718","volume":"2","author":"McChesney","year":"1961","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB57","first-page":"692","article-title":"Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity","volume":"12","author":"Finbloom","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3949\/ccjm.24.2.98","article-title":"Comparison of the effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthritis","volume":"24","author":"Scherbel","year":"1957","journal-title":"Cleveland Clin Q"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB59","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00270580","article-title":"Histological and ultrastructural findings in chloroquine-induced cardiomyopathy","volume":"73","author":"August","year":"1995","journal-title":"J Mol Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.1965.00460300018003","article-title":"Vacuolar myopathy","volume":"12","author":"Rewcastle","year":"1965","journal-title":"Arch Neurol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0002-9343(87)90444-X","article-title":"Chloroquine neuromyotoxicity","volume":"82","author":"Estes","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.0954-6820.1977.tb16857.x","article-title":"Cardiomyopathy after chloroquine treatment","volume":"202","author":"Magnussen","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcp\/29.5.455","article-title":"Vacuolar myopathy in systemic lupus erythematosus","volume":"29","author":"Pearson","year":"1958","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/rheumatology\/34.2.166","article-title":"Incidence of myopathy in patients treated with antimalarials","volume":"34","author":"Avina-Zubieta","year":"1995","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB66","first-page":"687","article-title":"Systemic lupus erythematosus and the cardiovascular system: The heart. Systemic Lupus Erythematosus","author":"Petri","year":"1999"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB67","first-page":"1642","article-title":"Hydroxychloroquine myopathy","volume":"25","author":"Richards","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB68","first-page":"808","article-title":"Discontinuation of antimalarial drugs in systemic lupus erythematosus","volume":"26","author":"Wang","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000117135","article-title":"Respiratory failure associated with hydroxychloroquine neuromyopathy [letter]","volume":"35","author":"Seguin","year":"1995","journal-title":"Eur Neurol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB70","first-page":"2927","article-title":"Hydroxychloroquine neuromyotoxicity","volume":"27","author":"Stein","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-8703(70)90371-6","article-title":"The effects of acute chloroquine poisoning with special reference to the heart","volume":"79","author":"Don Michael","year":"1970","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB72","first-page":"45","article-title":"Acute cardiotoxicity of chloroquine and hydroxychloroquine in dogs","volume":"49","author":"Lansimies","year":"1971","journal-title":"Ann Med Exp Biol Fenn"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB73","first-page":"454","article-title":"Chloroquine; pathologic changes observed in rats which for two years had been fed various proportions","volume":"45","author":"Nelson","year":"1948","journal-title":"Arch Pathol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB74","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/ajem.2001.25774","article-title":"Treatment of hydroxychloroquine overdose","volume":"19","author":"Marquardt","year":"2001","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0167-5273(83)90136-5","article-title":"Complete heart block in chronic chloroquine poisoning","volume":"4","author":"Ladipo","year":"1983","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB76","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6120.1109","article-title":"Complete heart block due to chronic chloroquine toxicity managed with permanent pacemaker","volume":"1","author":"Edwards","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.81.2.221","article-title":"Chloroquine cardiomyopathy with conduction disorders","volume":"81","author":"Baguet","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB78","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/hrt.37.9.982","article-title":"Complete heart block and systemic lupus erythematosus","volume":"37","author":"Wray","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJM198701223160405","article-title":"Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy","volume":"316","author":"Ratliff","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB80","first-page":"953","article-title":"Chloroquine-induced cardiomyopathy","volume":"111","author":"McAllister","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/hrt.69.5.451","article-title":"Restrictive cardiomyopathy caused by chloroquine","volume":"69","author":"Cubero","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB82","first-page":"85","article-title":"Chloroquine myopathy","volume":"40","author":"Hughes","year":"1971","journal-title":"Q J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB83","first-page":"1394","article-title":"Complete heart block as a rare complication of treatment with chloroquine","volume":"26","author":"Reuss-Borst","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.60.3.301","article-title":"Cardiac toxicity secondary to long term treatment with chloroquine [letter]","volume":"60","author":"Cervera","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB85","first-page":"768","article-title":"Weekly clinicopathological exercises","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB86","first-page":"234","article-title":"Les troubles de conduction au cours du lupus \u00e9ryth\u00e9mateux","volume":"132","author":"Godeau","year":"1981","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB87","first-page":"800","article-title":"Troubles de la conduction cardiaque au cours d\u2019un traitement prolong\u00e9 par chloroquine","volume":"21","author":"Verny","year":"1992","journal-title":"Presse Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB88","first-page":"501","article-title":"Chloroquine neuromyopathy","volume":"38","author":"Whisnant","year":"1963","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB89","first-page":"236","article-title":"Cardiac abnormalities in SLE","volume":"9","author":"Biji","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB90","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/sarh.2001.23498","article-title":"Coronary artery disease in systemic lupus erythematosus","volume":"30","author":"Karrar","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0889-857X(05)70138-1","article-title":"Premature atherosclerosis in systemic lupus erythematosus","volume":"26","author":"Bruce","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB92","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specificincidence rates of myocardial infarction and angina in women with systemic lupus erythematosus","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB93","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB94","first-page":"1323","article-title":"Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use [letter]","volume":"27","author":"Rahman","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1084\/jem.124.4.635","article-title":"Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet: I. Effect of repeated injection of horse serum in rabbits fed a dietary cholesterol supplement","volume":"124","author":"Minick","year":"1966","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB96","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002281-200109000-00001","article-title":"Accelerated atherosclerosis in systemic lupus erythematosus","volume":"13","author":"Salmon","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0889-857X(21)00233-7","article-title":"Antimalarial agents and lupus","volume":"20","author":"Wallace","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB98","first-page":"1874","article-title":"Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis","volume":"20","author":"Tett","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009747409115809","article-title":"Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus","volume":"3","author":"Laaksonen","year":"1974","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00129784-200202050-00001","article-title":"Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics","volume":"2","author":"Terra","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.semarthrit.2003.09.012_BIB101","first-page":"9","article-title":"Myocyte survival pathways and cardiomyopathy","volume":"27","author":"Chien","year":"2000","journal-title":"Semin Oncol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017203001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017203001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T09:24:55Z","timestamp":1623749095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017203001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0049017203001690"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2003.09.012","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}